-
-
-
-
-
-
-
BridgeBio Pharma (BBIO) PT Raised to $110 at Mizuho
-
-
-
-
-
-
-
Akeso's ivonescimab beats durvalumab in biliary tract cancer trial
-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Belite Bio (BLTE) Reiterated at Buy by Benchmark on Tinlarebant NDA Acceptance by FDA
-
-
-
-
-
-
-
Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy
-
-
-
-
-
-
-
Cogent (COGT) PT Raised to $52 at Guggenheim
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Summit Therapeutics plc (SMMT)
-
15,747 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

